The study aims to assess the safety and efficacy of Viaskin Peanut to induce desensitization to peanut in peanut-allergic children 1 to 3 years of age after a 12-month treatment by EPicutaneous ImmunoTherapy (EPIT)
Your child is invited to participate because your child has a peanut allergy. The study will last up to 72 weeks where you will take daily study drug, monthly study injections, complete study questionnaires/diaries, food challenge, skin prick tests, breathing tests, and have your blood drawn.
For Dupilumab there are common risks such as: conjunctivitis (pink eye), injection site reaction (swelling, redness, etc.), your child may experience a local or generalized allergic reaction (also known as a hypersensitivity reaction).
Parents or caregivers of a child with ADHD ages 6, 7 or 8 are invited to participate in a study to reduce ADHD symptoms. Parents are asked to complete surveys at two or three time points and to complete a six-week online course called the Nurtured Heart Approach.
The Oral Bacterial Extract (ORBEX) Study is a three year study to see whether the wheezing and lower respiratory tract illnesses that lead to asthma can be prevented. The goal is to find if a medication that is used in Europe, called Broncho-Vaxom®, can prevent wheezing lower respiratory infections in young children. It may work to stimulate a child’s immune system in order to increase the body’s defenses against germs that cause children to have respiratory illnesses.
We are looking for families with a child or adolescent with a diagnosis of type 1 diabetes to participate in a study examining the effects of an intervention to assist families with their daily routines. Assessments and the intervention consultation address sleep, school, and family activities that may help or interfere with diabetes management.
This study will consist of a brief survey (approximately 5 min) examining the family history and behaviors of mothers who have previously given birth. Our goal is to examine birth outcomes to improve maternal-child health. You will receive a children's book for your participation.
Do you have a daughter between the ages of 9 and 11 years of age? Researchers at the University of Arizona are conducting a HPV vaccine study that may interest you! HPV is short for human papillomavirus, a common virus. HPV vaccines are usually given as a series of three injections over 6 months to protect against HPV-related cancers and diseases. This new HPV vaccine study is recruiting 9-11 year-old girls to determine if one injection of the HPV vaccine will produce long-term immune response.